rs114232513
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_033305.3(VPS13A):āc.6410A>Gā(p.Glu2137Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000989 in 1,568,116 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0053 ( 8 hom., cov: 31)
Exomes š: 0.00053 ( 4 hom. )
Consequence
VPS13A
NM_033305.3 missense
NM_033305.3 missense
Scores
10
8
Clinical Significance
Conservation
PhyloP100: 4.89
Genes affected
VPS13A (HGNC:1908): (vacuolar protein sorting 13 homolog A) The protein encoded by this gene may control steps in the cycling of proteins through the trans-Golgi network to endosomes, lysosomes and the plasma membrane. Mutations in this gene cause the autosomal recessive disorder, chorea-acanthocytosis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.00822413).
BP6
Variant 9-77339547-A-G is Benign according to our data. Variant chr9-77339547-A-G is described in ClinVar as [Benign]. Clinvar id is 367401.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-77339547-A-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00532 (805/151224) while in subpopulation AFR AF= 0.0184 (760/41240). AF 95% confidence interval is 0.0173. There are 8 homozygotes in gnomad4. There are 394 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS13A | NM_033305.3 | c.6410A>G | p.Glu2137Gly | missense_variant | 48/72 | ENST00000360280.8 | NP_150648.2 | |
VPS13A | NM_001018037.2 | c.6293A>G | p.Glu2098Gly | missense_variant | 47/71 | NP_001018047.1 | ||
VPS13A | NM_015186.4 | c.6410A>G | p.Glu2137Gly | missense_variant | 48/69 | NP_056001.1 | ||
VPS13A | NM_001018038.3 | c.6410A>G | p.Glu2137Gly | missense_variant | 48/69 | NP_001018048.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS13A | ENST00000360280.8 | c.6410A>G | p.Glu2137Gly | missense_variant | 48/72 | 1 | NM_033305.3 | ENSP00000353422.3 | ||
VPS13A | ENST00000376636.7 | c.6293A>G | p.Glu2098Gly | missense_variant | 47/71 | 1 | ENSP00000365823.3 | |||
VPS13A | ENST00000643348.1 | c.6410A>G | p.Glu2137Gly | missense_variant | 48/69 | ENSP00000493592.1 | ||||
VPS13A | ENST00000645632.1 | c.6410A>G | p.Glu2137Gly | missense_variant | 48/69 | ENSP00000496361.1 |
Frequencies
GnomAD3 genomes AF: 0.00533 AC: 806AN: 151112Hom.: 8 Cov.: 31
GnomAD3 genomes
AF:
AC:
806
AN:
151112
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00134 AC: 251AN: 186742Hom.: 2 AF XY: 0.000998 AC XY: 99AN XY: 99154
GnomAD3 exomes
AF:
AC:
251
AN:
186742
Hom.:
AF XY:
AC XY:
99
AN XY:
99154
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000527 AC: 746AN: 1416892Hom.: 4 Cov.: 35 AF XY: 0.000422 AC XY: 296AN XY: 700960
GnomAD4 exome
AF:
AC:
746
AN:
1416892
Hom.:
Cov.:
35
AF XY:
AC XY:
296
AN XY:
700960
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00532 AC: 805AN: 151224Hom.: 8 Cov.: 31 AF XY: 0.00534 AC XY: 394AN XY: 73780
GnomAD4 genome
AF:
AC:
805
AN:
151224
Hom.:
Cov.:
31
AF XY:
AC XY:
394
AN XY:
73780
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
56
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
162
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:5
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, Amsterdam University Medical Center | - | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | May 31, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Chorea-acanthocytosis Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Nov 11, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;.;D;.;.;.;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;.;.;D;D;D
MetaRNN
Benign
T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.;M;M;M;M;M
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D;D;D;.;.;.
REVEL
Benign
Sift
Uncertain
D;D;D;D;.;.;.
Sift4G
Uncertain
D;D;D;D;.;.;.
Polyphen
B;B;B;B;B;B;B
Vest4
MVP
MPC
0.39
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at